D-0090-2024 Class II Terminated
FDA drug recall D-0090-2024 was initiated by Amneal Pharmaceuticals Of New York, LLC on Oct 27, 2023 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Aug 6, 2025). Affected quantity: 9,263 100-count bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 15, 2023
- Initiation Date
- Oct 27, 2023
- Termination Date
- Aug 6, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 9,263 100-count bottles
Product description
Extended Phenytoin Sodium Capsules, USP, 100 mg, 100-count bottle, Distributed by Amneal Pharmaceuticals LLC Bridgewater, NJ, 08807, NDC# 65162-212-10
Reason for recall
Failed Dissolution Specifications
Distribution pattern
Nationwide in the USA and Puerto Rico
Code information
Lot # HM03221A, Exp. date 12/31/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0090-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026